If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,236.00    -7.00 (-0.56%)
Bid:
1,234.00
Ask:
1,236.00
Spread: 2.00 (0.162%)
Market Cap: £854.29m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

17 Jul 2009 07:00

RNS Number : 8283V
CVS Group plc
17 July 2009
 



For Immediate Release

17 July 2009

CVS Group plc

("CVS" or the "Company")

Acquisition

Acquisition of the Falkland Veterinary Clinic, Newbury

We are pleased to announce the acquisition of the Falkland Veterinary Clinic which has been established for over 20 years. The acquisition further strengthens the Company's existing presence in this geographic area.  

CVS will assume all management responsibilities for the Falkland Veterinary Clinic following completion of the acquisition including the current employees, which comprise seven professional vets amongst a total staff of 25. In line with CVS' strategy, administration will be consolidated within the Company's central facilities, providing significant cost synergies and benefits following the acquisition.

In the year ended 30 April 2009, Falkland achieved profit before tax of £52,000 on turnover of approximately £1 million. This acquisition is a trade and asset purchase and CVS will only be acquiring the stocks and £218,000 of fixed assets. The consideration for the acquisition is being met entirely from internally generated cash.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "The Falkland Veterinary Clinic is a well established clinic with over two decades of experience in animal care and which recently relocated to state of the art facilities. We are therefore delighted to be making this addition to our portfolio of veterinary clinics and surgeries and look forward to working with them to help continue the high level of animal care and customer service that they have been delivering to date."

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Buchanan Communications

Mark Edwards

Ben Romney 

020 7466 5000

Panmure Gordon

Richard Gray

Andrew Godber

020 7459 3600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQILFIRDEIRLIA
Date   Source Headline
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options
15th Dec 202111:30 amRNSPDMR/PCA Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.